A new 'one-two punch' method for improving checkpoint inhibitor therapy for cancers, including Hodgkin lymphoma
Checkpoint inhibitor therapies can be thought of as the molecular "brake release" for the immune system. These drugs eliminate the protein barriers that impede the immune system from recognizing and targeting cancer cells ...
Jun 20, 2024
0
42